Karolinska Institutet Innovation

What Karolinska Institutet Innovation does

Karolinska Institutet Innovation AB (formerly KI Innovations AB) is the integrated life science innovation arm of Karolinska Institutet, operating as a wholly-owned subsidiary of KI Holding AB from its headquarters at Nanna Svartz väg 2 in Solna, Sweden. The organization supports researchers and entrepreneurs in transforming academic discoveries into commercial life science products across biotech, medtech, diagnostics, digital health, and pharma. Its service portfolio is organized around four interconnected offerings: the Innovation Lab (early-stage feasibility and idea validation), KI Science Park (a 62-member community providing coworking and lab access via A Working Lab), the KI Incubator or DRIVE program (a competitive, application-based incubator currently supporting 64 companies), and Access to Capital (direct venture co-investment and curated deal flow for external investors).

The business model combines public grant funding — notably a top-tier allocation from VINNOVA, Sweden's government innovation agency — with equity participation in selected early-stage portfolio companies. Innovation support services to KI-affiliated researchers are provided free of charge; Science Park membership and incubator participation have undisclosed fees. Direct venture investments generate returns through equity appreciation and follow-on rounds, as evidenced by participation in HAGA.BIO's SEK 20.9 million and OneTwo Analytics' SEK 12 million financings in 2026. Co-investment partners include Almi Invest, Life Science Invest, SU Ventures, the Silverstein Dream Foundation, and international VCs; the 2025 InvestorDay convened 70+ investors.

Go-to-market is event-driven and community-led, centered on monthly Business Breakfasts, Innovation Roundtables, CEO and Business Leader Lunches, the annual InvestorDay, and KI Science Park Day, supplemented by digital content (website, newsletters, LinkedIn, Facebook, Instagram) and webinars. Strategic alliances include AbbVie Scandinavia (Golden Ticket program), STING (deep-tech life science co-calls), UIC (Catalyzer accelerator), SciLifeLab (research infrastructure), Akademiska Hus (facilities), Potter Clarkson and Høiberg (pro bono IP advice), and portfolio-friendly corporates such as Genovis. Leadership comprises CEO Johan Weigelt (also CEO of KI Holding AB), Director of KI Science Park Sara Gunnerås, and Business Advisor – Capital Acquisition Teodora Andonova.

Name

Karolinska Institutet Innovation

Legal name

Karolinska Institutet Innovation AB

Website

https://kiinnovation.se

Company type

Private

Founded year

2022

Operating status

Operating

Short description

Karolinska Institutet Innovation AB is the integrated life science innovation arm of Karolinska Institutet, operating an Innovation Lab, incubator (DRIVE), Science Park community, and direct venture function to help researchers and entrepreneurs build investable biotech, medtech, and digital health companies.

Ownership category

akta.pro rank

Product category

Life Science Innovation Services

NAICS

Management, Scientific, and Technical Consulting Services (5416), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742), Investment Advice (6282)

akta.pro primary industry

Technical Universities with Entrepreneurship & Incubation Focus (EDAHAEAH)

akta.pro secondary industries

Applied Research & Innovation Universities (EDAHAEAE), Technical Universities with Strong Industry Partnerships (EDAHAEAG)

Keywords

• Life science innovation
• Startup incubation services
• Venture capital investing
• Science park community
• Biotech accelerator programs

Headquarters

HQ city

Solna

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Venture Capital Returns: KI Innovation invests in selected early-stage companies and generates returns through equity appreciation, exits, and follow-on investments. The organization participates in funding rounds as an existing investor (e.g., co-investing in OneTwo Analytics, investing in HAGA.BIO).
2. Innovation Support Services: Provides business development, coaching, feasibility assessment, and commercialization support to researchers and startups. Services are offered as part of the innovation ecosystem, likely funded through Karolinska Institutet and public innovation agencies (Vinnova).

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

Karolinska Institutet Innovation is the integrated life science innovation ecosystem affiliated with Karolinska Institutet, providing four interconnected services: the Innovation Lab for early-stage researcher support and feasibility assessment, the KI Incubator (DRIVE) for scaling life science startups with business development coaching, KI Science Park as a community hub with coworking and lab facilities, and Access to Capital offering direct venture co-investment and curated deal flow to external investors.

Product overview

Karolinska Institutet Innovation operates as an integrated life science innovation ecosystem with four interconnected service offerings: the Innovation Lab for early-stage researcher support, KI Science Park as a community platform connecting startups and industry, the KI Incubator (DRIVE) for scaling startups, and Access to Capital for investment and funding network connections. The organization serves researchers, entrepreneurs, and companies across the life science sector, providing expertise, structure, networks, and capital access from early ideas through to growing companies.

Differentiator

Problem solved

Functional benefit

Brands

• KI Science Park: A dynamic environment where startups, industry and academia meet, fostering partnerships across the life science ecosystem.
• Innovation Lab
• KI Incubator / DRIVE

Products and services

• Innovation Lab Early-stage support program that helps researchers assess feasibility, shape their idea, and identify the right path forward toward real-world application — whether building a company or collaborating with others. Open to both KI-affiliated researchers and external innovators.
• KI Science Park A dynamic community environment where startups, industry, and academia meet to create opportunities, exchange knowledge, and build meaningful partnerships across the life science ecosystem. Includes coworking space, lab facilities (via A Working Lab), networking events, and industry partnerships. The community has 62 member companies.
• KI Incubator (DRIVE) Business incubator that supports early-stage life science startups with structured business development coaching, investor readiness preparation, and resources to achieve international success. Companies are competitively admitted into the program, which has a portfolio of 64 active and alumni companies.
• Access to Capital Venture investment function that invests equity in selected early-stage life science companies and connects portfolio ventures with a broad network of investors, family offices, and venture capital firms. Includes co-investment opportunities for external investors and curated deal flow. KI Innovation has co-invested in companies such as HAGA.BIO and OneTwo Analytics.

Quantifiable outcome

• KI Innovations InvestorDay 2025 gathered over 70 investors including business angels and international VCs
• +3 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered flagship, major, core and supporting.

• AbbVie ScandinaviaflagshipStrategic or Co-development Partner · 2 October 2025KI Innovation partnered with AbbVie, a global biopharmaceutical company, to launch the AbbVie Scandinavia Golden Ticket — a program providing one promising life science company with resources, mentorship, and access to AbbVie's network. Serendo Therapeutics won the 2026 edition. This is the second edition of the partnership.
• STINGmajorStrategic or Co-development Partner · 5 February 2025STING (Stockholm Innovation & Growth) and KI Innovations collaborated on a call for deep tech Life Science innovators. STING is a Swedish incubator and accelerator supporting deep tech and life science startups.
• Akademiska HuscoreOthersAkademiska Hus is one of Sweden's largest property companies and a strategic partner in providing physical infrastructure for the KI Science Park ecosystem at Campus Solna. They collaborate with universities to reinforce Sweden's research environment.
• A Working Lab (Innomedicum)majorStrategic or Co-development PartnerA Working Lab operates coworking, office space, and lab facilities for academia and companies in life sciences at Innomedicum (Campus Solna). KI Science Park co-organizes events including Business Breakfasts at the AWL Café within Innomedicum. Locations include both Campus Solna and AWL Flemingsberg.
• Science for Life Laboratory (SciLifeLab)majorTechnology or IntegrationThe Drug Discovery and Development (DDD) platform at SciLifeLab collaborated with Professor Sophie Erhardt's team to establish high-throughput screening assays and screen 33,000+ compounds for novel psychosis treatments. SciLifeLab provides essential research infrastructure for KI Incubator companies.
• UIC (Uppsala Innovation Centre)majorStrategic or Co-development PartnerKI Innovations co-runs the Catalyzer accelerator program with UIC and Uppsala Innovation Centre. The program provides business development support for health and life science startups across multiple Swedish innovation hubs.
• Potter ClarksonsupportingImplementation/ SI/ Consulting PartnerPotter Clarkson provides free patent advice sessions for Karolinska Institutet researchers and staff, helping innovators assess intellectual property protection strategies.
• HøibergsupportingImplementation/ SI/ Consulting PartnerHøiberg is a full-service patent law firm providing free patent advice services with extensive life science experience for KI-affiliated researchers and innovators.

Scale indicators8 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Medicon Village: Life science science park in Lund, Sweden, hosting startups, SMEs, and research organizations. Comparable as a Swedish regional life science innovation hub with co-location and community functions.
• Sahlgrenska Science Park: Life science innovation park affiliated with the University of Gothenburg and Sahlgrenska University Hospital. Comparable as a Swedish university-affiliated science park for life science companies.
• STING (Stockholm Innovation & Growth): Swedish incubator and accelerator supporting deep tech and life science startups. Directly comparable as a Swedish innovation hub that KI Innovation has formally partnered with on deep tech life science calls.
• Umeå Biotech Incubator (UBI): Swedish life science incubator supporting biotech and pharma startups with business development and investor readiness. Comparable in mandate and target customer base to KI Innovation's DRIVE incubator.
• BioInnovation Institute (BII): Danish life science incubator and venture builder offering funding, lab space, and business development to early-stage life science startups. Comparable as a Nordic life science venture incubator/investor with public funding support.
• Uppsala Innovation Centre (UIC): Swedish innovation center running the Catalyzer accelerator program jointly with KI Innovation. Comparable as a Swedish university-anchored innovation hub serving health and life science startups.

Broad incumbents

• JLABS (Johnson & Johnson Innovation): Global network of life science incubators run by Johnson & Johnson. Comparable as a no-strings-attached life science incubator with corporate backing, but broader in scope and resources than KI Innovation.
• AstraZeneca BioVentureHub: Swedish-based corporate life science hub where emerging biotech companies work alongside AstraZeneca. Comparable as a Sweden-based life science innovation hub with direct corporate involvement, though anchored to a single pharma company.

Regional players

• COBIS (Copenhagen Bio Science Park): Life science-focused co-working and incubator facility in Copenhagen, Denmark. Comparable as a Nordic life science park providing lab facilities and business support, though serving Danish rather than Swedish startups.

Others

• Karolinska Institutet Innovationskontor (academic TTO contrast): Karolinska Institutet's broader research and innovation infrastructure. Listed as an adjacent ecosystem participant connected to KI Innovation's Innovation Lab offering of feasibility assessment and IP support services for KI researchers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/KIInnovationsAB
• LinkedInlinkedin.com/company/karolinska-instututet-innnovation
• Instagraminstagram.com/kisciencepark

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Karolinska Institutet Innovation